(Q42987938)

English

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group

scientific article published on May 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 November 2017

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group (English)

1 reference

Europe PubMed Central

12 November 2017

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

A Kasahara

1

1 reference

Europe PubMed Central

12 November 2017

N Hayashi

2

1 reference

Europe PubMed Central

12 November 2017

K Mochizuki

3

1 reference

Europe PubMed Central

12 November 2017

M Takayanagi

4

1 reference

Europe PubMed Central

12 November 2017

K Yoshioka

5

1 reference

Europe PubMed Central

12 November 2017

S Kakumu

6

1 reference

Europe PubMed Central

12 November 2017

A Iijima

7

1 reference

Europe PubMed Central

12 November 2017

A Urushihara

8

1 reference

Europe PubMed Central

12 November 2017

K Kiyosawa

9

1 reference

Europe PubMed Central

12 November 2017

M Okuda

10

1 reference

Europe PubMed Central

12 November 2017

K Hino

11

1 reference

Europe PubMed Central

12 November 2017

K Okita

12

1 reference

Europe PubMed Central

12 November 2017

language of work or name

0 references

publication date

1 May 1998

1 reference

Europe PubMed Central

12 November 2017

1 reference

Europe PubMed Central

12 November 2017

27

1 reference

Europe PubMed Central

12 November 2017

1394-1402

1 reference

Europe PubMed Central

12 November 2017

5

1 reference

Europe PubMed Central

12 November 2017

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-alpha

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvement of liver fibrosis in chronic hepatitis C patients treated with natural interferon alpha

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of patients with chronic hepatitis C treated with α-interferon

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term biochemical and virological response to natural interferon-alpha in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment with recombinant interferon-alpha 2a for patients with chronic hepatitis C: predictive factors for biochemical and virologic response. Osaka Liver Disease Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

High levels of serum interleukin-10 are associated with a poor response to interferon treatment in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C. Relationship to interferon response

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

Pretreatment viral load and response to prolonged interferon-alpha course for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

A proposed system for the nomenclature of hepatitis C viral genotypes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection. Tokyo-Chiba Hepatitis Research Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus RNA transcripts and DNA in chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis. Le Groupe Français pour l'Etude du Traitement des Hépatites Chroniques NANB/C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for hepatocellular carcinoma among patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant interferon-α in inoperable hepatocellular carcinoma: A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) on human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C virus genotype and RNA titer in the progression of type C chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical backgrounds of the patients having different types of hepatitis C virus genomes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C virus genotypes are not responsible for development of serious liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270529

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.510270529

1 reference

Europe PubMed Central

12 November 2017

1 reference

Europe PubMed Central

12 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42987938&oldid=1975893063"